skip to main content

Deoxyribonucleoside treatment rescues EtBr‐induced mtDNA depletion in iPSC‐derived neural stem cells with POLG mutations

Kristiansen, Cecilie Katrin ; Furriol, Jessica ; Chen, Anbin ; Sullivan, Gareth John ; Bindoff, Laurence A. ; Liang, Kristina Xiao

The FASEB journal, 2023-09, Vol.37 (9), p.e23139-n/a [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
  • Título:
    Deoxyribonucleoside treatment rescues EtBr‐induced mtDNA depletion in iPSC‐derived neural stem cells with POLG mutations
  • Autor: Kristiansen, Cecilie Katrin ; Furriol, Jessica ; Chen, Anbin ; Sullivan, Gareth John ; Bindoff, Laurence A. ; Liang, Kristina Xiao
  • Assuntos: deoxynucleosides ; iPSCs ; mitochondrial DNA replication ; neural stem cells ; polymerase γ ; therapy
  • É parte de: The FASEB journal, 2023-09, Vol.37 (9), p.e23139-n/a
  • Notas: Laurence A. Bindoff and Kristina Xiao Liang share corresponding authorship.
    ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
  • Descrição: Mutations in POLG, the gene encoding the catalytic subunit of the mitochondrial DNA (mtDNA) polymerase gamma (Pol‐γ), lead to diseases driven by defective mtDNA maintenance. Despite being the most prevalent cause of mitochondrial disease, treatments for POLG‐related disorders remain elusive. In this study, we used POLG patient‐induced pluripotent stem cell (iPSC)‐derived neural stem cells (iNSCs), one homozygous for the POLG mutation c.2243G>C and one compound heterozygous with c.2243G>C and c.1399G>A, and treated these iNSCs with ethidium bromide (EtBr) to study the rate of depletion and repopulation of mtDNA. In addition, we investigated the effect of deoxyribonucleoside (dNs) supplementation on mtDNA maintenance during EtBr treatment and post‐treatment repopulation in the same cells. EtBr‐induced mtDNA depletion occurred at a similar rate in both patient and control iNSCs, however, restoration of mtDNA levels was significantly delayed in iNSCs carrying the compound heterozygous POLG mutations. In contrast, iNSC with the homozygous POLG mutation recovered their mtDNA at a rate similar to controls. When we treated cells with dNs, we found that this reduced EtBr‐induced mtDNA depletion and significantly increased repopulation rates in both patient iNSCs. These observations are consistent with the hypothesis that mutations in POLG impair mtDNA repopulation also within intact neural lineage cells and suggest that those with compound heterozygous mutation have a more severe defect of mtDNA synthesis. Our findings further highlight the potential for dNs to improve mtDNA replication in the presence of POLG mutations, suggesting that this may offer a new therapeutic modality for mitochondrial diseases caused by disturbed mtDNA homeostasis. POLG patient iPSCs‐derived iNSCs with two different mutations, one homozygous (WS5A) and one compound heterozygous (CP2A), were treated with EtBr to induce depletion of mtDNA. While depletion occurred at a similar rate, restoration of mtDNA levels was significantly delayed in CP2A iNSCs. Both patient lines showed post‐treatment alterations in gene expression of nucleotide metabolism‐related genes. Supplementation with deoxyribonucleosides (dNs) reduced EtBr‐induced mtDNA depletion and significantly increased repopulation rates in both patient iNSCs.
  • Idioma: Inglês;Norueguês

Buscando em bases de dados remotas. Favor aguardar.